Evidence map›Paper›PMID 29420642›Full record

ArticlePloS one2018

Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease.

Eleonora M Lad, Dibyendu Mukherjee, Sandra S Stinnett, Scott W Cousins, Guy G Potter, James R Burke, Sina Farsiu, Heather E Whitson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's Disease.Investigative ophthalmology & visual science · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eleonora M LadDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID 0000-0001-8435-521X
Dibyendu MukherjeeDepartment of Biomedical Engineering, Duke University Medical Center, Durham, North Carolina, United States of America.
Sandra S StinnettDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Scott W CousinsDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Guy G PotterJoseph and Kathleen Bryan Alzheimer's Disease Research Center, Durham, North Carolina, United States of America.
James R BurkeJoseph and Kathleen Bryan Alzheimer's Disease Research Center, Durham, North Carolina, United States of America.
Sina FarsiuDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Heather E WhitsonDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
NEI NIH HHS P30 EY005722
6 · The paper itself

Abstract

Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting in atrophy. The objective of our study was to determine whether retinal GCIPL (ganglion cell-inner plexiform layer) or nerve fiber layer (NFL) thickness may serve as noninvasive biomarkers to diagnose AD. This cross-sectional case-control study enrolled 15 mild cognitive impairment (MCI) patients, 15 mild-moderate AD patients, and 18 cognitively normal adults. NFL and GCIPL thicknesses on optical coherence tomography (OCT) were measured using Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP) and Spectralis software. We demonstrated that regional thicknesses of NFL or GCIPL on macular or nerve OCTs did not differ between groups. However, a multi-variate regression analysis identified macular areas with a significant thickening or thinning in NFL and GCIPL in MCI and AD patients. Our primary findings controvert previous reports of thinner NFL in moderate-to-severe AD. The areas of thickening of GCIPL and NFL in the macula adjacent to areas of thinning, as revealed by a more complex statistical model, suggest that NFL and GCIPL may undergo dynamic changes during AD progression.

Indexed as

AdultAgedAlzheimer DiseaseBiomarkersCognition DisordersFemaleHumansMaleMiddle AgedRetinaTomography, Optical CoherenceBiomarkers

Identifiers

PMID29420642
PMCPMC5805310
OpenAlexW2787939369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.